• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。

Severe renal failure following high-dose ifosfamide and mesna.

作者信息

Willemse P H, de Jong P E, Elema J D, Mulder N H

机构信息

Department of Internal Medicine, University Hospital Groningen, The Netherlands.

出版信息

Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.

DOI:10.1007/BF00292414
PMID:2495864
Abstract

A 62-year-old woman developed subacute renal failure after the repeated administration of ifosfamide (IFX), despite its combination with continuous sodium 2-mercaptoethane sulfonate (mesna) infusion. Biopsy findings, the possible underlying mechanism, and the existing literature are discussed.

摘要

一名62岁女性在反复使用异环磷酰胺(IFX)后出现亚急性肾衰竭,尽管同时持续输注2-巯基乙烷磺酸钠(美司钠)。本文讨论了活检结果、可能的潜在机制及现有文献。

相似文献

1
Severe renal failure following high-dose ifosfamide and mesna.大剂量异环磷酰胺和美司钠治疗后出现的严重肾衰竭。
Cancer Chemother Pharmacol. 1989;23(5):329-30. doi: 10.1007/BF00292414.
2
Irreversible encephalopathy with ifosfamide/mesna.异环磷酰胺/美司钠所致不可逆性脑病
J Clin Oncol. 1987 Aug;5(8):1303-4. doi: 10.1200/JCO.1987.5.8.1303.
3
Ifosfamide/mesna encephalopathy.异环磷酰胺/美司钠脑病
Lancet. 1987 Apr 25;1(8539):987. doi: 10.1016/s0140-6736(87)90343-6.
4
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.毒性及对大剂量异环磷酰胺+美司钠作为晚期乳腺癌挽救治疗的反应
J Cancer Res Clin Oncol. 1988;114(6):602-4. doi: 10.1007/BF00398184.
5
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.异环磷酰胺和美司钠治疗晚期卵巢癌的II期试验:一项妇科肿瘤学组研究
J Clin Oncol. 1989 Nov;7(11):1672-6. doi: 10.1200/JCO.1989.7.11.1672.
6
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Cancer Chemother Pharmacol. 1990;26 Suppl:S51-4. doi: 10.1007/BF00685420.
7
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.异环磷酰胺/美司钠治疗妇科恶性肿瘤的II期经验:妇科肿瘤学组研究的初步报告
Semin Oncol. 1989 Feb;16(1 Suppl 3):68-72.
8
High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.高剂量异环磷酰胺与美司钠治疗晚期乳腺癌:一项II期研究
Cancer Chemother Pharmacol. 1990;26 Suppl:S91-2. doi: 10.1007/BF00685432.
9
Encephalopathy with rapid infusion ifosfamide/mesna.快速输注异环磷酰胺/美司钠所致脑病
Lancet. 1987 Feb 14;1(8529):390-1. doi: 10.1016/s0140-6736(87)91769-7.
10
Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.与异环磷酰胺/美司钠化疗相关的致命性低钾血症
Lancet. 1988 May 14;1(8594):1116. doi: 10.1016/s0140-6736(88)91942-3.

引用本文的文献

1
Renal toxicity and chemotherapy in children with cancer.癌症患儿的肾毒性与化疗
Br J Clin Pharmacol. 2017 Dec;83(12):2605-2614. doi: 10.1111/bcp.13388. Epub 2017 Sep 20.
2
Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.异环磷酰胺和顺铂治疗三年后,皮质类固醇使核肿大性间质性肾炎病情改善。
CEN Case Rep. 2014 Nov;3(2):226-231. doi: 10.1007/s13730-014-0124-3. Epub 2014 Jun 4.
3
Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.

本文引用的文献

1
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).氮杂磷三环类细胞抑制剂的尿路毒性及其预防研究——III. 2-巯基乙烷磺酸钠(美司钠)的作用概况。
Eur J Cancer Clin Oncol. 1982 Dec;18(12):1377-87. doi: 10.1016/0277-5379(82)90143-2.
2
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.2-巯基乙烷磺酸钠(美司钠)未能预防异环磷酰胺所致的肾毒性。
Eur J Cancer Clin Oncol. 1984 Mar;20(3):435-6. doi: 10.1016/0277-5379(84)90093-2.
3
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
儿童恶性肿瘤治疗的晚期肾毒性:危险因素、长期结局和监测。
Pediatr Nephrol. 2018 Feb;33(2):215-225. doi: 10.1007/s00467-017-3662-z. Epub 2017 Apr 22.
4
Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.巨细胞样肾病变、尤文肉瘤和异环磷酰胺治疗。
Pediatr Nephrol. 2011 Jul;26(7):1163-6. doi: 10.1007/s00467-011-1815-z. Epub 2011 Mar 18.
5
Nephrotoxicity as a cause of acute kidney injury in children.肾毒性作为儿童急性肾损伤的一个病因
Pediatr Nephrol. 2008 Dec;23(12):2159-73. doi: 10.1007/s00467-007-0721-x. Epub 2008 Jan 29.
6
Anticancer drug-induced kidney disorders.抗癌药物引起的肾脏疾病。
Drug Saf. 2001 Jan;24(1):19-38. doi: 10.2165/00002018-200124010-00003.
7
How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group.复发性威尔姆斯瘤的可治愈性如何?英国儿童癌症研究组。
Arch Dis Child. 1990 Sep;65(9):968-70. doi: 10.1136/adc.65.9.968.
8
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
Cancer Chemother Pharmacol. 1990;26 Suppl:S51-4. doi: 10.1007/BF00685420.
9
Dosing and side-effects of ifosfamide plus mesna.异环磷酰胺加美司钠的剂量及副作用
J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S164-86. doi: 10.1007/BF01613224.
10
Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.异环磷酰胺诱发的肾性范科尼综合征的肾小管功能及组织学表现——两例报告
Eur J Pediatr. 1992 May;151(5):384-7. doi: 10.1007/BF02113264.
使用异环磷酰胺输注联合美司钠进行大剂量烷基化疗法治疗成人晚期软组织肉瘤。
Cancer Chemother Pharmacol. 1983;11(2):69-72. doi: 10.1007/BF00254247.
4
Ifosfamide--current aspects and perspectives.异环磷酰胺——当前状况与展望
Cancer Treat Rev. 1983 Sep;10 Suppl A:183-92. doi: 10.1016/s0305-7372(83)80027-9.
5
Clinical overview of mesna.美司钠的临床概述
Cancer Treat Rev. 1983 Sep;10 Suppl A:175-81. doi: 10.1016/s0305-7372(83)80026-7.
6
High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.高剂量异环磷酰胺和美司钠持续输注五天——一项I/II期试验。
Cancer Treat Rev. 1983 Sep;10 Suppl A:167-73. doi: 10.1016/s0305-7372(83)80025-5.
7
Unexpected toxicity in patients treated with iphosphamide.接受异环磷酰胺治疗的患者出现意外毒性。
Cancer Res. 1972 May;32(5):921-4.
8
VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S45-50. doi: 10.1007/BF00647451.
9
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
Cancer Res. 1987 Mar 1;47(5):1457-60.
10
Mesna--a short review.美司钠——简短综述。
Cancer Treat Rev. 1987 Jun;14(2):67-86. doi: 10.1016/0305-7372(87)90041-7.